Related Experiment Video
Updated: Jan 10, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Natural antioxidant substances improve oxidative stress and alleviate ulcerative colitis: a meta-analysis of
Shuo Yuan1, Lingling Cai2, Man Su3
1Department of General Surgery, Beilun Branch of the First Affiliated Hospital of Zhejiang University, Ningbo, China.
Abstract:
Oxidative stress is a key driver of mucosal damage in ulcerative colitis (UC). Antioxidant supplementation may restore redox balance, but its clinical efficacy remains controversial. To evaluate the effects of natural antioxidant substances supplementation on oxidation/antioxidant biomarkers and clinical outcomes in UC patients. The databases included PubMed, Embase, Web of Science, and Cochrane Library (up to July 2025) were searched, and RCTs comparing oral antioxidants with placebo in UC were included. The primary outcomes were changes in oxidative stress markers (MDA, SOD, TAC, GPX). The secondary outcomes included the short IBD questionnaire (SIBDQ) score and the simple clinical colitis activity index (SCCAI) score. 9 articles involving 624 patients were included in this study. Compared to placebo group, antioxidant substances supplementation could significantly reduce the level of MDA (P = 0.001, SMD=-1.09, 95% CI -1.75 to -0.43), increased the levels of SOD, TAC, GPX in patients with UC (P = 0.02, SMD = 0.57, 95% CI 0.10 to 1.04; P = 0.0004, SMD = 0.74, 95% CI 0.33 to 1.16; P = 0.004, SMD = 0.69, 95% CI 0.22 to 1.16). In addition, antioxidant substances supplementation remarkably decreased the SCCAI score of UC patients (P = 0.04, SMD=-0.62, 95% CI -1.21 to -0.04), thus improving the disease activity. However, there is no significant difference in the change of IBDQ score (P = 0.13, SMD = 0.55, 95% CI -0.17 to 1.28). Natural antioxidant substances supplementation effectively enhanced antioxidant capacity and ameliorated oxidation status, improved the disease activity of UC patients, but had no significant impact on their quality of life. This study will provide a basis for the selection of adjuvant therapy drugs for UC.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

